title: Can we prevent blood dyscrasia (leucopenia, thrombocytopenia) and epileptic seizures induced by clozapine.
authors.affiliation: Psychiatric Hospital Vrapce, Bolnicka cesta 32, HR-10090 Zagreb, Croatia. miroslav.herceg@bolnica-vrapce.hr
authors.forename: Miroslav
authors.initials: M
authors.lastname: Herceg
authors.forename: Lana
authors.initials: L
authors.lastname: Muzinić
authors.forename: Vlado
authors.initials: V
authors.lastname: Jukić
mesh_terms: D000328:Adult; D000380:Agranulocytosis / Q000097:blood / Q000139:chemically induced* / Q000517:prevention & control; D000927:Anticonvulsants / Q000627:therapeutic use; D018692:Antimanic Agents / Q000009:adverse effects / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity*; D003024:Clozapine / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000097:blood / Q000139:chemically induced* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000097:blood / Q000139:chemically induced* / Q000517:prevention & control*; D016651:Lithium Carbonate / Q000009:adverse effects / Q000627:therapeutic use; D011618:Psychotic Disorders / Q000097:blood / Q000188:drug therapy*; D012008:Recurrence; D012307:Risk Factors; D012559:Schizophrenia / Q000097:blood / Q000188:drug therapy; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000175:diagnosis / Q000523:psychology; D013921:Thrombocytopenia / Q000097:blood / Q000139:chemically induced* / Q000517:prevention & control*
chemical_list: D000927:Anticonvulsants; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D016651:Lithium Carbonate; D003024:Clozapine